ArticleLife (Basel, Switzerland)2025

Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use.

Raquel Santos-Juanes Galache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.